Showing 11,461 - 11,480 results of 104,042 for search '(( a step decrease ) OR ( 5 ((ng decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.65s Refine Results
  1. 11461
  2. 11462

    Genes in extracellular clusters E1-5. by Gareth A. Cromie (17118013)

    Published 2024
    “…Here, we examine colony development in a yeast strain (F13) that produces colonies with a highly structured “ruffled” phenotype in the colony periphery and an unstructured “smooth” phenotype in the colony center. …”
  3. 11463
  4. 11464

    Preconditioning anti-VEGF antibody decreased IR-induced pulmonary edema and microvascular hyper-permeability. by Chou-Chin Lan (2938674)

    Published 2016
    “…<p><b>(A)</b> Lung weight (LW) and wet/dry weight (W/D) was significantly increased in the IR group (p<0.05) and decreased in the B5-IR (p<0.05). …”
  5. 11465
  6. 11466
  7. 11467
  8. 11468
  9. 11469

    Preconditioning anti-VEGF antibody decreased total protein concentration and pro-inflammatory cytokines in BALF. by Chou-Chin Lan (2938674)

    Published 2016
    “…Preconditioning anti-VEGF antibody (5 mg/kg) decreased IR-induced total protein concentration and TNF-α in BALF (both <i>p</i><0.05). …”
  10. 11470

    Belinostat decreases both male and female bladder weights in transgenic superficial bladder cancer mice by Michael T Buckley (37161)

    Published 2011
    “…Normal non-transgenic mouse bladders weigh approximately 10.0 mg at the same age, and Ha-transgenic mice with superficial bladder cancer have a 3 fold and higher bladder weight. , Male belinostat-treated mice (n = 4, 327.5 mg average weight) showed a two-fold decrease (50%, p = 0.03) in bladder weight versus control (n = 4, 652.5 mg average weight). , Female belinostat-treated mice (n = 5, 34.0 mg average weight) showed a 36% decrease (p = 0.04) in bladder weight versus control (n = 6, 53.3 mg average weight).…”
  11. 11471
  12. 11472
  13. 11473
  14. 11474
  15. 11475

    <i>DAPK1</i> Promoter Methylation and Cervical Cancer Risk: A Systematic Review and a Meta-Analysis by Antonella Agodi (638417)

    Published 2015
    “…The aim of the present study was to carry out a systematic review and a meta-analysis in order to evaluate <i>DAPK1</i> promoter methylation as an epigenetic marker for CC risk.…”
  16. 11476
  17. 11477
  18. 11478

    Trial Sequential Analysis, parallel group trials, decreased appetite, nausea, vomiting, and abdominal pain. by Mathilde Holmskov (4112062)

    Published 2017
    “…A) Decreased appetite: The required information size was 14,286 participants. …”
  19. 11479

    Decreased chondrocytes proliferation, shortening of pre-hypertrophic and hypertrophic zone in BMP signaling deficient mice. by Bettina Keller (231677)

    Published 2011
    “…(G–I) BrdU staining revealed a decreased proliferation rate in <i>Smad1<sup>cKO/cKO</sup>;Smad5<sup>+/−</sup></i> compared to WT control (P<0.02).…”
  20. 11480